The FGF23–Undercarboxylated Osteocalcin Axis in Predialysis Chronic Kidney Disease: Linking Mineral Homeostasis and Bone Turnover
- 1Department of Physiology and Pathophysiology, Medical University–Pleven, 1 Kliment Ohridski Str., 5800 Pleven, Bulgaria
- 2Hemodialysis Unit, St. Marina Hospital, 5800 Pleven, Bulgaria
- 3Department of Biomedical Science, Faculty of Veterinary Medicine, Medical University–Pleven, 1 Kliment Ohridski Str., 5800 Pleven, Bulgaria
Abstract
Fibroblast growth factor 23 (FGF23) and osteocalcin are involved in mineral and bone metabolism, but their relationship in chronic kidney disease (CKD) remains insufficiently characterized. This cross-sectional study investigated the association between FGF23 and undercarboxylated osteocalcin (Glu-OC) and whether this association persisted after accounting for kidney function. The study included 80 adults: 12 healthy controls and 68 patients with non-dialysis CKD stages G1–G4. Associations were assessed using Spearman correlation, partial correlation adjusted for estimated glomerular filtration rate (eGFR), and complementary multivariable linear regression models. Among patients with CKD, FGF23 was inversely correlated with eGFR (ρ = −0.346, p = 0.004) and Glu-OC (ρ = −0.344, p = 0.004), and positively correlated with serum creatinine (ρ = 0.299, p = 0.013). The inverse association between FGF23 and Glu-OC persisted after adjustment for eGFR (partial ρ = −0.475, p < 0.001). In the multivariable regression models, Glu-OC was inversely associated with FGF23 (standardized β = −0.258, p = 0.024), whereas alkaline phosphatase was positively associated with FGF23 (β = 0.369, p = 0.001). In the model with Glu-OC as the dependent variable, FGF23 (β = −0.266, p = 0.020) and serum calcium (β = −0.366, p = 0.002) were inversely associated with Glu-OC. Significant inverse correlations between FGF23 and Glu-OC were observed in CKD stages G1–G3, but not in stage G4 or the control group. These findings support an association between FGF23 and Glu-OC in non-dialysis CKD and provide a rationale for further investigation of a potential FGF23–Glu-OC axis in CKD-associated mineral and bone disorder (CKD-MBD). Longitudinal and mechanistic studies are needed to clarify the nature and clinical relevance of this association.
Related
- Lysophospholipase PNPLA7 is a critical checkpoint of phosphatidylcholine catabolism and turnover for skeletal muscle homeostasis
- Lactoferrin Modulates Intestinal Morphology and Microbiota Homeostasis in Chronic Social Defeat Stress Mice
- Role of Osteocalcin in the Regulation of Glucose Metabolism in Children and Adolescents with Obesity
- Association Between Glycemic Variability and Bone Turnover and the Sema3A Signaling Pathway in Postmenopausal Women with Type 2 Diabetes Mellitus
- The heart-liver axis controls platelet turnover by hepatic STAT3 phosphorylation and TPO regulation after acute myocardial infarction
BibTeX
@article{simeonova2026fgf23undercarboxylated,
title = {{The FGF23–Undercarboxylated Osteocalcin Axis in Predialysis Chronic Kidney Disease: Linking Mineral Homeostasis and Bone Turnover}},
author = {Tatyana Simeonova and Borislav Ignatov and Tsvetelina Eftimova and Alexander Blazhev and Krasimir Kostov},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27219743},
url = {https://www.mdpi.com/1422-0067/27/21/9743},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The FGF23–Undercarboxylated Osteocalcin Axis in Predialysis Chronic Kidney Disease: Linking Mineral Homeostasis and Bone Turnover
AU - Tatyana Simeonova
AU - Borislav Ignatov
AU - Tsvetelina Eftimova
AU - Alexander Blazhev
AU - Krasimir Kostov
PY - 2026
DA - 2026/10/30
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27219743
UR - https://www.mdpi.com/1422-0067/27/21/9743
AB - Fibroblast growth factor 23 (FGF23) and osteocalcin are involved in mineral and bone metabolism, but their relationship in chronic kidney disease (CKD) remains insufficiently characterized. This cross-sectional study investigated the association between FGF23 and undercarboxylated osteocalcin (Glu-OC) and whether this association persisted after accounting for kidney function. The study included 80 adults: 12 healthy controls and 68 patients with non-dialysis CKD stages G1–G4. Associations were assessed using Spearman correlation, partial correlation adjusted for estimated glomerular filtration rate (eGFR), and complementary multivariable linear regression models. Among patients with CKD, FGF23 was inversely correlated with eGFR (ρ = −0.346, p = 0.004) and Glu-OC (ρ = −0.344, p = 0.004), and positively correlated with serum creatinine (ρ = 0.299, p = 0.013). The inverse association between FGF23 and Glu-OC persisted after adjustment for eGFR (partial ρ = −0.475, p < 0.001). In the multivariable regression models, Glu-OC was inversely associated with FGF23 (standardized β = −0.258, p = 0.024), whereas alkaline phosphatase was positively associated with FGF23 (β = 0.369, p = 0.001). In the model with Glu-OC as the dependent variable, FGF23 (β = −0.266, p = 0.020) and serum calcium (β = −0.366, p = 0.002) were inversely associated with Glu-OC. Significant inverse correlations between FGF23 and Glu-OC were observed in CKD stages G1–G3, but not in stage G4 or the control group. These findings support an association between FGF23 and Glu-OC in non-dialysis CKD and provide a rationale for further investigation of a potential FGF23–Glu-OC axis in CKD-associated mineral and bone disorder (CKD-MBD). Longitudinal and mechanistic studies are needed to clarify the nature and clinical relevance of this association.
SN - 1422-0067
ER -